The SMA gene therapy candidate OAV101 IT, a version of Zolgensma, can be safely given to previously treated patients, per new trial data.

SMA News Today is providing live coverage of the MDA Clinical & Scientific Conference taking place March 16-19 in Dallas. Stay tuned to this page for all the latest news.

Thanks to the 21st Century Cures Act, columnist Brianna Albers tends to needlessly stress about lab results her doctor hasn't yet reviewed.